Ensign Peak Advisors’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99K Hold
3,535
﹤0.01% 1569
2025
Q4
$132K Sell
3,535
-9,850
-74% -$324K ﹤0.01% 1480
2025
Q3
$369K Hold
13,385
﹤0.01% 1514
2025
Q2
$423K Hold
13,385
﹤0.01% 1598
2025
Q1
$444K Hold
13,385
﹤0.01% 1578
2024
Q4
$461K Hold
13,385
﹤0.01% 1621
2024
Q3
$535K Hold
13,385
﹤0.01% 1588
2024
Q2
$404K Hold
13,385
﹤0.01% 1649
2024
Q1
$449K Sell
13,385
-675
-5% -$21.7K ﹤0.01% 1645
2023
Q4
$454K Buy
14,060
+2,350
+20% +$65.6K ﹤0.01% 1674
2023
Q3
$384K Hold
11,710
﹤0.01% 1651
2023
Q2
$412K Hold
11,710
﹤0.01% 1671
2023
Q1
$382K Buy
11,710
+300
+3% +$13.7K ﹤0.01% 1685
2022
Q4
$629K Buy
11,410
+7,150
+168% +$393K ﹤0.01% 1527
2022
Q3
$189K Buy
4,260
+880
+26% +$42.9K ﹤0.01% 1894
2022
Q2
$165K Hold
3,380
﹤0.01% 1850
2022
Q1
$164K Buy
3,380
+3,090
+1,066% +$126K ﹤0.01% 1932
2021
Q4
$12K Buy
+290
New +$11.6K ﹤0.01% 2188

Other funds holding HRMY